Discover a New Path to Relief with Spravato

This innovative nasal spray therapy could be the next step in your healing journey.

Why Choose Spravato?

  • FDA-Approved for Treatment-Resistant Depression & Suicidal Ideation

  • Safe, Monitored In-Office Administration

  • Covered by Most Insurance Plans

  • Supervised by Compassionate, Licensed Mental Health Providers

  • Personalized Care Plans & Ongoing Support

Spravato (esketamine) Treatment Proven Effective for
Treatment-Resistant Depression

You may benefit from adding SPRAVATO® to your existing oral antidepressant if you’re an adult with major depressive disorder (MDD) who has had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD).

SPRAVATO® is the only FDA-approved nasal spray for TRD

  • SPRAVATO® is an NMDA receptor antagonist that is believed to work differently by acting on a pathway in the brain that affects glutamate

🪴 What to Expect:

  • A calm, welcoming treatment room designed for your comfort

  • 2-hour supervised sessions by licensed medical professionals

  • Coordination with a psychiatrist and psychiatric nurse practitioner

  • Ongoing assessments to track your progress and safety

Reach out to our Spravato Administrator Today!

Watch Short Informational Videos on Spravato which answers your questions about:

  • What is treatment resistant depression?

  • What makes Spravato different from oral antidepressants?

  • What can I expect about my first treatments?

  • What does Spravato treat and what are the side effects?

  • Why is there an observation period after taking Spravato?

  • How often will I take Spravato?

  • How soon might I see improvement in Spravato